Skip to main content
VulnerabilityPublished Updated

CVE-2020-14477: Philips Ultrasound ClearVue · CWE-288

Affects Philips Ultrasound ClearVueSource CVE Database V5

0

Not known to be exploited · CVSS 3.6 Low.

Data as of 26 Oct 2026, 11:42 UTC

CVSS 3.1 base score
3.6Low
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 22% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 26 Jun 2020

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
Philips Ultrasound ClearVueAffected
  • =0
Fixed in–

AI-suggested

European healthcare organizations should implement strict network segmentation to isolate ultrasound devices from general IT networks, limiting local access to trusted personnel only. Physical security controls should be enhanced to prevent unauthorized access to the devices. Network monitoring should be employed to detect unusual access patterns or attempts to connect to alternate service channels. Organizations should engage with Philips to obtain any available firmware updates or patches addressing this vulnerability and apply them promptly. In the absence of official patches, consider disabling or restricting access to alternate service logins if configurable. Regular audits of device configurations and access logs can help identify potential exploitation attempts. Additionally, staff training on the importance of device security and adherence to access policies is critical. Finally, ensure that incident response plans include procedures for medical device compromise scenarios to minimize patient impact.

Description

In Philips Ultrasound ClearVue Versions 3.2 and prior, Ultrasound CX Versions 5.0.2 and prior, Ultrasound EPIQ/Affiniti Versions VM5.0 and prior, Ultrasound Sparq Version 3.0.2 and prior and Ultrasound Xperius all versions, an attacker may use an alternate path or channel that does not require authentication of the alternate service login to view or modify information.

References

Community reviews

Loading reviews…